Using Noble-prize winning bioorthogonal chemistry, California-based Shasqi (NSF-1660258) created a technology that delivers high doses of chemotherapy to cancerous cells without impacting nearby tissue. Shasqi uses hydrogel polymers to localize chemotherapy drug delivery, and is the first company to use click chemistry to fight human disease. Article via Healio